Open-label Treatment in Cushing's Syndrome

Completed · Phase 3

Conditions studied: Cushing Syndrome, Cushing Disease

In brief

This is a long-term, open-label extension study of levoketoconazole in participants with endogenous Cushing's Syndrome.

Key facts

Study ID
NCT03621280
Run by
Cortendo AB
People needed
51
Starts
2019-01-07
Expected to finish
2022-12-31
Last updated by the study team
2025-06-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.